| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vistagen Therapeutics, Inc. (VTGN) has 12 insiders with recent SEC Form 4 filings, including 2 buys and 0 sells. VTGN is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 75.0K | $45.8K | - | |
| CFO | 75.0K | $45.8K | - | |
| CEO | 71.3K | $43.5K | - | |
| COO | 56.2K | $34.3K | - | |
| Other | 56.2K | $34.3K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 31, 2017 | Gin Jerry B | Director | Buy | 100,000 | $0.00 | - | +200.0% |